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Resumo 
 
Introdução: A dermatite atópica (AD) é uma doença de pele comum, crónica e 
multifatorial que acarreta um enorme custo para o paciente e directa e indirectamente, 
também para os serviços de saúde e sociedade de forma geral. Um dos principais 
sintomas, sinal clínico e que mais afecta a qualidade de vida dos pacientes com esta 
patologia, é o prurido. O prurido atópico está associada à carga inflamatória, 
caracterizada por uma multiplicidade de mecanismos. Esta patologia pode ser muito difícil 
de tratar e não responde bem aos medicamentos anti-histamínicos. Tal como acontece 
com muitas outras doenças crónicas e ou difíceis de tratar, os pacientes buscam ajuda 
desesperada em estratégias alternativas ou medicinas complementares, como a 
medicina tradicional chinesa (MTC). Existem vários relatos que o MTC, em geral, e a 
acupuntura em particular, podem ser úteis para o tratamento do prurido e / ou da 
dermatite atópica. 
 
Objetivo: Realizar uma revisão sistemática de literatura sobre a acupuntura como uma 
medida terapêutica distinta para o tratamento do prurido associada à dermatite atópica, 
com base nos Critérios Principais Itens para Relatar Revisões sistemáticas e Meta-
análises (PRISMA) para avaliar sua eficácia e segurança na prática clínica. 
 
Métodos: Foi realizada pesquisa bibliográfica de ensaios controlados randomizados, 
(RCT) em 3 base de dados médicos: Pubmed, Web of Science e SCOPUS, com base em 
regras de pesquisa padronizadas. Foram incluídos estudos que compararam os efeitos 
da acupuntura com os de placebo, ou pseudoacupuntura, ou nenhuma intervenção, na 
intensidade, duração e / ou sinais e sintomas da Dermatite atópica. 
 
Resultados: A pesquisa inicial produziu 104 artigos, dos quais 26 foram excluídos, uma 
vez que foram duplicados, e 67 após uma leitura cuidadosa do título e do resumo. 11 
estudos foram selecionados para revisão detalhada de texto completo. Destes, apenas 2 
descreviam o tratamento do prurido atópica em contextos clínicos; Um deles por 
acupressão, o outro por acupuntura. O último, no entanto, não era suficientemente 
controlado, portanto, excluído, assim como o primeiro, porque se tratava de auto-
tratamento, através de acupressão. Em resumo, não encontramos nenhum estudo que 
fosse elegível para ser incluído nesta revisão sistemática. 
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Conclusão: Não encontramos estudos de alta qualidade sobre o tratamento do prurido 
atópica por acupuntura em contextos clínicos e, portanto, não podemos fazer 
recomendações baseadas em evidências, com base nesta revisão. No entanto, 
identificamos vários estudos que demonstraram a eficácia da acupuntura na indução de 
histamina e prurido induzido por alérgenos, em voluntários saudáveis e bem como em 
pacientes atópicos. Encontramos, também, evidências de que a acupuntura e a 
acupressão são capazes de modificar o prurido atópica, na prática clínica, no entanto, 
não em RCT e apenas em estudos com reduzido numero de pacientes. Portanto, 
concluímos que RCTs rigorosamente projetados e controlados para avaliar a eficácia da 
acupuntura no manejo da coceira atópica na prática clínica são necessários para 
esclarecer sua utilidade como monoterapia. 
  
Palavras-chave: acupuntura, atópico, prurido, prurido 
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Abstract 
 
Introduction: Atopic dermatitis (AD) is a common multifactorial chronic skin disease that 
causes immense disease burden on patients and enormous direct and indirect health care 
costs for societies. One of the main symptoms and the leading clinical sign but also one of 
the  most quality of life affecting problems in AD is itch. Atopic itch is associated with the 
inflammatory burden and characterized by a multitude of mechanisms. It can be very 
difficult to treat and does not respond well to antihistaminic drugs. As with many other 
chronic and difficult to treat diseases or symptoms patients seek desperately help in 
alternative or complementary medicine strategies such as traditional chinese medicine 
(TCM) and others. There are various reports that TCM in general and acupuncture in 
particular can be helpful for the treatment of itch and / or AD.  
 
Objective: To systematicallly review the literature on acupunture as one distinct 
therapeutic measure for the treatment of itch associated with atopic dermatitis based on 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement to evaluate its efficacy and safety in clinical practice. 
 
Methods: Literature searches for randomized controlled trials (RCT) were conducted in 
three medical databases (Pubmed, Web of Science and SCOPUS) based on 
standardized searching rules. Included were studies comparing the effects of acupuncture 
with those of placebo- or pseudoacupuncture or no intervention on itch intensity, duration 
and/or signs and symptoms of AD. 
 
Results: The initial search yielded 104 articles, 26 of which were excluded as they were 
duplicates and 67 after carefull reading of title and abstract. 11 studies qualified for 
detailed full text review. Only 2 of these described the treatment of atopic itch in clinical 
settings; one of them by acupressure, the other one by acupuncture. The latter was 
however not sufficiently controlled and therefore excluded as well as the first one because 
it was on self-applied acupressure. In summary we did not find any studies that were 
eligible to be included in this systematic review.  
 
Conclusion: High quality studies on the treatment of atopic itch by acupuncture in clinical 
settings could not be identified and therefore no evidence-based recommendations can be 
made based on this review. However, several studies that demonstrated the effectiveness 
of acupuncture on histamine induced and allergen induced itch in healthy volunteers and 
atopic patients as well were identified. In addition, evidence that acupuncture and 
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acupressure are able to modify atopic itch in clinical practice were found, however not in a 
RCT and only with very small patient numbers. Therefore the conclusion of this review is 
that rigorously designed and controlled RCTs to assess the efficacy of acupuncture in the 
management of atopic itch in clinical practice are needed to clarify its usefullness as 
monotherapy. 
 
Keywords: acupuncture, atopic, itch, pruritus 
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"O princípio da ciência é sabermos que ignoramos."  
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1. INTRODUCTION 
 
1.1 Atopic Dermatitis 
 
Atopic dermatitis (AD) is a non-contagious, multifactorial chronic inflammatory skin 
disease occurring often in families with atopic diseases (namely: atopic dermatitis, 
bronchial asthma and/or allergic rhino-conjunctivitis). Manifestation factors are genetic 
predisposition factors on one hand and various internal and/or external triggers on the 
other (Werfel et al., 2014). The varying etiologic concepts of this disease have lead to a 
variety of different names that are or have been used for the condition, such as "atopic 
dermatitis or eczema", "neurodermatitis", "neurodermitis", "endogenous or constitutional 
eczema".  
 
The atopic diseases are genetically linked, and the concordance ranges from  80% in 
monozygotic twins to 30% in dizygotic twins. Described genetic polymorphisms in AD 
involve mediators of atopic inflammation on a variety of  chromosomes, some of these are 
also relevant for respiratory atopy. The strongest association has been demonstrated for 
mutations in the filaggrin gene that is also associated with ichthyosis vulgaris. This is a 
clear hint to the importance of a predisposing barrier defect in AD patients. The skin 
barrier dysfunction can be quantified by measuring the transepidermal water loss (Ring et 
al., 2012a).  
 
The cumulative incidence of AD ranges between 11 and 21% in Northern Europe 
depending on age and region with a recorded  point prevalence of e.g. 10–15 % in 
Germany. According to epidemiologic analyses about 23 % of babies and toddlers, 8 % of 
schoolchildren and 2-4 % of adults claim healthcare services because of AD in that 
country. AD can diminish over time but at least 30% of all children that suffer from atopic 
dermatitis will have eczema in adulthood.   
 
AD is an eosinophilic and spongiotic inflammatory disease of the skin with characteristic 
age-dependent distribution patterns and morphology of lesions. There is no specific 
marker to diagnose AD so that the diagnosis should be made by using evaluated clinical 
criteria. This requires a medical history (including personal and family atopic history) and 
examination of the whole skin organ. Dermatohistopathologal examination of a skin biopsy 
can be necessary at times to rule out other inflammatory diseases (such as e.g. 
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cutaneous T cell lymphoma), but even then other eczematous diseases cannot always be 
distinguished. Most diagnostic criteria are based on cutaneous signs of atopy. Hanifin and 
Rajka’s criteria include: pruritus, typical morphology and distribution, chronic or chronically 
relapsing course, and atopic personal or family history (3 of 4 necessary), in addition to 
three minor criteria among a list of 21 (Wollenberg et al., 2016).  
 
Disease activity can be measured with a composite score assessing both objective signs 
and subjective symptoms, such as the so called SCORAD (Severity Scoring of Atopic 
Dermatitis) or the EASI (Eczema Area and Severity Index) (Chalmers et al., 2016). The 
management of AD must consider the clinical and pathogenic variabilities of the disease 
and also target flare prevention. Diagnostic and treatment guidelines have been 
developed in different countries and by different societies (e.g. Ring et al., 2012a/b; Rubel 
et al., 2013; Werfel et al., 2016). 
 
The most important basic therapeutic measure is regularly applied hydrating topical 
treatment and prevention of irritation and/or exsiccation (e.g. by overhygiene, excessive 
washing procedures etc.). Other specific and/or unspecific provocation factors should also 
be avoided if known. Anti-inflammatory treatment of visible skin lesions is based on topical 
glucocorticosteroids and topical calcineurin inhibitors. Tacrolimus and mid-potent steroids 
are proven for "proactive therapy", which is long-term intermittent (e.g. once weekly) anti-
inflammatory local therapy on the frequently relapsing skin areas (Wollenberg A et al., 
2016). Systemic anti-inflammatory or immunosuppressive treatment is indicated for 
severe and or refractory cases. Biologicals targeting key mechanisms of the atopic 
immune response are promising emerging treatment options and have been licensed very 
recently (Hanifin, 2016). Microbial colonization and superinfection may cause disease 
exacerbation and justify additional antimicrobial treatment in such instances. Adjuvant 
therapy includes UV irradiation, preferably UVA1 or narrow-band UVB 311 nm. Dietary 
recommendations should be patient specific and elimination diets should only be advised 
in case of proven food allergy. Allergen-specific immunotherapy to aeroallergens may be 
useful in selected cases. Psychosomatic counselling is recommended to address stress-
induced exacerbations. "Eczema school" educational programmes have been proven to 
be helpful for children and adults (Werfel et al., 2014). 
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1.2 Itch 
 
Itch has been defined by the German physician Samuel Hafenreffer in 1660 as 
"unpleasant sensation, that elicits the desire to scratch" (Hafenreffer, 1660; Carlsson and 
Wallengren, 2010). It is one of the leading symptoms of AD without which the diagnosis 
cannot be made. It´s severity can range from mild to extremely severe depending on the 
physiological state of the skin, the degree of skin inflammation, the size of the area 
involved, the duration and also the patient´s perception. Itch can influence a patient´s 
quality of life dramatically up to mutilating scratching and even suicide. Very frequently 
itch causes severe sleep disturbances with following physical and psychological 
exhaustion.  
 
Reception of itch is by free nerve endings in the epidermis, papillary dermis and around 
skin appendages that are activated by various endogenous and exogenous pruritogens 
through respective receptors. Itch is then mediated by unmyelinated C-fiber afferents and 
thinly myelinated Ad fiber afferents originating from cell bodies in the dorsal root ganglion. 
The skin-nerve interface is altered in atopic skin, with increased innervation density and 
expression of several inflammatory neuropeptides (eg, substance P, calcitonin gene–
related peptide, and vasoactive intestinal peptide) in lesional atopic skin. Numerous 
exogenous stimuli (eg, irritants and relevant allergens) and endogenous factors (such as 
histamine, cytokines, neuropeptides, and other inflammatory molecules) activate the 
above mentioned receptors (Mollanazar et al., 2016).  
 
Particularly histamine is one of the major itch mediators that has been well evaluated. 
Direct application of histamine to human skin induces itching and a subsequent axonal 
reflective vasodilation clinically visible as flare. Two of four known histamine receptors, 
namely H1R and H4R have been identified as potential pruritoceptors. Topical and oral 
antihistamines (drugs with antihistamine action) are routinely recommended by physicians 
to help control atopic itch. Despite this widespread practice, histamine’s role in triggering 
itch in AD is still limited and evidence supporting the use of histamine 1 (H1) or histamine 
2 (H2) receptor antagonists in AD management is sparse. Emerging evidence suggests 
that the H4 receptor may play an important role in mediating histamine-induced 
inflammation and itch in AD; however, H4 antagonists are currently not commercially 
available. In addition, histamine mediated itch represents just one kind of itch relevant in 
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AD and there are nonhistaminergic pathways that are equally important (Mollanazar et al., 
2016). Recent neuroimaging studies have focused on brain imaging of histamine-induced 
itch in humans. It was demonstrated in functional neuroimaging studies that acute 
histamine-induced itch captivates the anterior cingulate cortex, insular and primary 
somatosensory cortex, premotor and supplementary motor areas, prefrontal cortex, and 
thalamus in healthy persons (Napadow et al., 2015).   
 
AD patients experience an even broader excitation of the brain.  When itching skin lesions 
are scratched, a brain region known as the "reward system" is much more reactive than 
when non itching skin is scratched. Therefore it was concluded that activation of the 
"reward system" may be one reason for the sometimes overly excessive and repetitive 
scratching behavior of AD patients. In addition, central sensitization, perception and 
interpretation of pruritus in AD patients are strongly influenced by cognitive and affective 
processes. Interestingly in that context, Napadow and coworkers could recently show, that 
nocebo saline applied to AD patients could mimic both the sensory and the neural effects 
of real allergens. They  argued that this provides an insight to the brain mechanisms 
supporting nocebo-induced itch in AD and thereby aides to the understanding of the role 
of expectations and other psychological factors in modulating itch perception in chronic 
itch patients (Napadow et al., 2015). This may be the basis of the itch dampening effect of 
centrally CNS-modulating drugs (reviewed in Kido-Nakahara et al., 2017).  
 
The repertoire of pruritogens is expanded in AD such that normally nonpruritogenic and/or 
painful stimuli (such as acetylcholine and bradykinin) can cause itch rather than pain. 
Inflammatory cytokines such as interleukin (IL)-31 are elevated in atopic skin and can 
directly activate peripheral receptors to induce itch signaling. Pathogenic bacteria and 
yeast that often colonize the skin of eczema patients may also directly activate peripheral 
nerves and thereby exacerbate itch. In addition, patients with atopic eczema can 
experience so called alloknesis, which is abnormal itch sensations elicited by normally 
nonitchy (e.g. thermal, or mechaninc, e.g. by wool clothing) stimuli. A wide range of other 
"exacerbators" of itch in AD are well known such as perspiration, psychological factors 
(stress) or scratching (Murota and Katayama, 2017). 
 
The central projections of the above mentioned afferent nerve fibers send itch signals to 
second order spinal neurons in the dorsal horn of the spinal cord, which in turn project to 
the ventrocaudal part of the nucleus medialis dorsalis in the thalamus via the contralateral 
spinothalamic tract and then onto higher cortical areas. The sensation of itch is perceived 
after activation of the somatosensory cortex and a subsequent scratching reflex is 
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generated in the motor cortex and associated motor cortex. The intensity and quality of 
itch signals can be influenced at various points along these peripheral, spinal, and/or 
cortical pathways by other ascending inputs from the periphery (e.g., other incoming pain 
or tactile or temperature-evoked sensations) and also by descending neural circuits (e.g., 
influence of mood and attention). Understanding these modulatory circuits is of particular 
interest and relevance in atopic itch because neurophysiologic and psychomimetric testing 
demonstrates that patients with AD exhibit reduced thresholds for itch and above 
mentioned alloknesis (the ability of a nonpruritic stimulus to evoke itch) in involved and 
uninvolved skin (reviewed in Elmariah, 2017; Mollanazar et al., 2016; Kido-Nakahara et 
al., 2017; Katayama et al., 2017).  
 
Exacerbations of AD often start as increased itch without visible skin lesions - which has 
led to the label: "…the itch that rashes…." -  followed by erythema, papules and 
infiltration. As stated above, systemic antihistamines targeting H1R are used in acute AD 
flares against itch. In general, antihistamines are safe to use, also for a long period of time 
and the major advantage seems to be relief of the symptoms of co-morbidities such as 
allergic asthma, rhino-conjunctivitis, urticarial dermographism and urticaria (Werfel et al., 
2014). Topical antihistamines have no effect on itch beyond that of their cooling vehicles 
(mostly as a gel) and are in contrast often times clinically not helpful since they exsiccate 
the skin via this galenic mechanism and even aggrevate itch that way. In summary there 
are limited data for the antipruritic effect of antihistamines (H1-antagonists) in AD and the 
effect of both first and second generation antihistamines on pruritus, in patients suffering 
from AD. The first generation of sedative antihistamines, such as hydroxyzine, clemastine 
fumarate and dimetinden maleate, may allow a better sleep pattern in acute situations 
with exacerbations of eczema. Long-term use in children is not recommended. Ongoing 
studies concentrate on the blockade of alternative histamine receptors such as H4R, 
which may be more important in AD.  
 
Antipruritic therapy in AD is multidimensional treating the symptom itself, the contributing 
factors such as dry skin, inflammation and the related scratch lesions. Therefore, several 
general measures are recommended. Short-term relief of pruritus can be achieved by 
topical creams or ointments containing urea, menthol, or camphor as well as wet, cooling 
or fat-moist wrappings, wrappings with black tea. Therefore even the use of these so 
called basic therpay measures needs to be controlled in clinical studies on itch and AD. 
The anti-inflammatory effect of topical corticosteroids in AD is well established and it has 
been shown that corticosteroids have a rapid antipruritic effect and can also be used in so 
called "proactive therapy" (Wollenberg et al., 2016). Most likely the anti-inflammatory 
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effect of glucocorticosteroids is the mechanism that helps suppress the itch. The same 
applies for systemic glucocorticosteroids, for which no specific studies on an anti-itch 
effect in AD are available.  
 
Biological treatments using anti–IL-31 receptor A or anti–IL-4 receptor alpha appear to be 
beneficial in reducing atopic itch (Hanifin, 2016). Combined therapy with conventional 
topical remedies and these biologics may provide new treatment strategies for atopic 
patients.  
 
In addition, all patients should be educated on how best to repair and reinforce the skin 
barrier in efforts to limit access to infection, irritants, or allergens, all of which stimulate or 
aggravate itch. Use of topical anesthetics or systemic neuromodulators can dampen itch 
signaling and may limit neural sensitization when used sufficiently early and used 
consistently. Finally, addressing physical and emotional stress is integral to an effective 
therapeutic regimen (reviewed in Mollanazar et al., 2016; Ring et al, 2012a/b; Zeidler et 
al., 2016). 
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1.3 Atopic dermatitis and itch in traditional chinese medicine 
 
As with many other chronic and difficult to treat diseases or symptoms patients seek 
desperately help in alternative or complementary medicine strategies such as traditional 
chinese medicine (TCM) and others (Augustin et al., 2012a).  
 
A recent AD treatment guideline quantified this growing interest in complementary 
alternative treatment (CAT or complementary alternative medicine, CAM) as treatment for 
AD. According to Ring et al., (2012a) France (49%) and Germany (46%) have the highest 
usage of CAM in Europe. The growing interest in CAM in the public was also seen in the 
United States, where an increase in the usage of CAM from 33.8% to 42.1% from 1990 
and 1997 was observed. In Switzerland 37% of 202 inpatients with atopic disorders said 
to have used CAM previously; most frequently homoeopathy (48%), diet (35%) and 
herbalism (28%), autologous blood injection (28%), phytotherapy (20%) and acupuncture 
(18%). From 444 inpatients with AD in Norway 51% reported the previous use of CAM, 
most frequently homoeopathy (34%), herbalism (19%), food supplements (18%), diet 
change (18%) and acupuncture (11%). In a German population-based telephone survey 
26.5% of adults with allergies claimed that they had used CAM, most commonly 
homoeopathy (35.3%), autologous blood injection (28.1%), acupuncture (16.6%) and 
bioresonance (10.0%) (reviewed in Ring et al., 2012b).  
 
Although CATs are becoming increasingly used in the management of chronic skin 
diseases, such as AD, few high-quality studies addressed their efficacy. A recent 
comprehensive meta-analysis of RCTs of CATs demonstrated efficacy of acupuncture 
and acupressure, hypnosis, massage, biofeedback, balneotherapy, herbal preparations, 
and oral evening primrose oil (Elmariah, 2017). 
 
Another very recent (2017) systematic review by Shi and coworkers looked at traditional 
Chinese medicines and related therapies such as acupuncture and moxibustion and did 
not find statistical differences in clinical effectiveness, SCORAD amelioration, and SSRI 
(Symptom Score Reducing Index) amelioration for these AD treatments compared with 
the respective control groups. They claimed, however to have found EASI (Eczema Area 
and Severity Index) amelioration by traditional Chinese medicines and related treatments 
for AD as being superior to control groups and treatments, respectively.  
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They concluded that although they were able to find Eczema Area and Severity Index 
(EASI) amelioration in the meta-analysis they presented, the clinical meaning of these 
findings would be restricted by the low number of included articles. In summary they did 
not find a superiority of traditional Chinese medicine and related treatments in AD therapy 
(Shi et al., 2017). 
 
Two years earlier Viera et al. published a systematic review on complementary and 
alternative medicine for AD and basically found what they called some "level I" evidence 
to support the use of acupuncture and acupressure, stress-reducing techniques such as 
hypnosis, massage, and biofeedback, balneotherapy, herbal preparations (with many 
important caveats), certain botanical oils, oral evening primrose oil, vitamin D 
supplementation, and topical vitamin B12. They saw despite the heterogeneity among 
many of the studies they looked at, their mostly small sizes, and their relatively low quality 
enough evidence to support the use of selected complementary and alternative therapies 
for AD. They concluded that they hoped with more RCTs and comparative efficacy studies 
alternative treatments could become mainstream in time (Vieira et al., 2016). 
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1.4 Acupuncture for the treatment of itch 
 
Carlsson and Wallengren (2010)  speculated that sensory cutaneous innervation, which is 
often dense in neuropathic pruritus, prurigo nodularis and in uremic pruritus is the main 
target of acupuncture in pruritic skin. They cited in their comprehensive review several 
studies that demonstrated efficacy of acupuncture for neuropathic and uremic itch such as 
a retrospective study that showed symptomatic relief of neuropathic pruritus in 12 of 16 
patients and a study of six patients with intractable pruritus secondary to chronic renal 
failure ameliorated by electrical needle stimulation at an acupoint on the elbow (LI11), 
whereas control treatment with superficial electrical stimulation was ineffective. Another 
study randomized 40 patients with refractory uraemic pruritus into two groups and applied 
acupuncture unilaterally on acupoint LI11 in one group three times weekly for 1 month. In 
the control group, acupuncture was applied at a non-acupoint 2 cm lateral from the elbow. 
Subjects responded to a pruritus score questionnaire given before and at the end of the 1-
month treatment and at a 3-month follow-up and pruritus scores were reduced by about 
50% after acupuncture and at the 3-month follow-up while they were unchanged in the 
control group. 
 
Ma and colleagues recently (2015) reviewed systemically the use of acupuncture as a 
primary treatment modality for dermatologic conditions. They claimed to have identified 24 
studies, 16 of which were RCTs. Acupuncture was used to treat atopic dermatitis, 
urticaria, pruritus, acne, chloasma, neurodermatitis, dermatitis herpetiformis, 
hyperhidrosis, human papillomavirus warts, breast inflammation, and facial elasticity. In 17 
of 24 studies, acupuncture showed statistically significant improvements in outcome 
measurements compared with placebo acupuncture, alternative treatment options, and/ or  
no intervention. They concluded that acupuncture can improve outcome measures in the 
treatment of dermatitis, chloasma, pruritus, urticaria, hyperhidrosis, and facial elasticity.  
For future studies they asked for clear standardizing of the control intervention, 
exemplified with placebo acupuncture as the control for the evaluation of  the validity of 
acupuncture points and meridians, blinding of participants to treatment modalites and 
blinding of acupuncturists to the disease being treated to exclude psychological and 
procedural bias in an area already prone to subjectivity (Ma et al., 2015). 
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Tan and coworkers aimed to evaluate the efficacy of acupuncture against placebo/sham 
acupuncture in the management of AD in systematic literature review in 2015. They 
included only studies comparing the effects of acupuncture with those of placebo/sham 
acupuncture on severity of disease or symptoms/signs of AD and did not find any studies 
that were eligible to be included in their systematic review (Tan et al., 2015).   
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1.5 Acupuncture for the treatment of atopic itch  
 
Salameh et al. published in 2008 a clinical study of 20 patients with mild-to-severe AD that 
were given a combined treatment of acupuncture and Chinese herbal medicine. The 
patients received acupuncture treatments twice a week and a Chinese herbal formula 
three times daily for a total of twelve weeks. After 12 weeks of treatment, an improvement 
in EASI (Eczema Area and Severity Index) was noted in all patients and 78.8% of patients 
experienced a reduction in DLQI (Dermatology Quality of Life Index) and VAS (visual 
activity score) for itch. They did not observe adverse effects.  
Yu et al. published in 2015 a systematic literature review and meta-analysis to assess the 
efficacy of acupuncture therapy against itch. They included RCTs that compared 
acupuncture therapy and placebo acupuncture or no treatment group and claimed to have 
found three articles of randomized controlled trials (RCTs) from a total of 2530 articles. In 
their opinion they were able to show in their meta-analysis that acupuncture therapy was 
effective to alleviate itch compared with placebo acupuncture and no treatment groups. In 
conclusion they cautiously suggested that acupuncture therapy is effective for 
ameliorating itch intensity in itch-related diseases (Yu et al., 2015). 
The latest version of the German guidelines for AD lists acupuncture as procedure that 
was not considered to be included because there was not enough evidence for it´s 
efficacy (Werfel et al., 2016b). 
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1.6. Rationale for this review in the context of what is known - PICOS 
 
 
The basic efficacy of acupuncture for the treatment of several forms of itch - meaning itch 
in several disease entities - seems proven by the existing literature as outlined above. 
With respect to the very complex mechanisms of itch in patients with AD that in addition 
can be influenced by various internal and external factors, the question of this systematic 
literature review is whether there is robust data on the efficacy of acupuncture for the 
treatment of atopic itch in a clinical context - meaning in ameliorating itch in daily patients´ 
lives. 
 
 
In short PICOS means in the context of this review therefore: 
 
Participants  - AD patients with (atopic) itch   
Interventions  - acupuncture as monotherapy  
Comparisons  - control interventions or no treatment 
Outcomes  - amelioration of atopic itch (over time)   
Study design - randomized controlled trial (RCT) 
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2. MATERIALS AND METHODS 
 
2.1. Search Strategy / Protocol 
The systematic literature search was performed according to the "Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA)" guidelines (Moher et al., 
2009). Three databases (Pubmed, Web of Science and SCOPUS) were searched in 
August 2017 from their inception up to August 2017. The search string for all three 
databases was: ((acupoint* OR acupuncture OR electroacupuncture OR moxibustion OR 
moxa) AND (pruritus OR itch) AND atopi* AND (skin OR derm*)). The reference chapters / 
bibliographies of standard textbooks and the articles searched (regardless if included or 
excluded)  were also checked for additional literature.  
 
2.2. Study Selection Criteria 
The study / article selection was performed according to the following inclusion criteria: (1) 
full-text randomized controlled trials, (2) related to the treatment of itch in atopic dermatitis 
patients, (3) criteria for the diagnosis of atopic dermatitis are given (e.g. SCORAD, EASI), 
(4) acupuncture as only treatment modality (monotherapy), (5) acupoints are given, (6) 
quantified measure of outcome (e.g. VAS for improvement of itch), (7) at least abstract in 
English available. Exclusion criteria for articles / studies were: (1) animal studies, (2) 
diagnoses other than clearly defined atopic dermatitis (e.g. urticaria, contact dermatitis 
etc.), (3) combination treatments (e.g. with herbs), (4) case reports, comments, reviews, 
editorials etc. 
 
2.3. Data Extraction and Management  
Data of selected articles were extracted by the author and independently reviewed by a 
second investigator. Both checked in depth inclusion and exclusion criteria by full text 
analysis of the papers. The literature characteristics comprised the following items: (1) 
author and publication year; (2) study design; (3) number of individuals in treatment and 
control groups; (4) participants’ age; (5) and gender; (6) diagnostic criteria for AD (where 
applicable); (7) allergen used (where applicable); (8) Treatment(s): Acupoint(s) / Duration / 
Frequency / Comedications (where applicable); (9) Control Intervention(s); (10) Outcome 
measure(s); (11) results; and (12) side effects and are listed in Tables 1-3.  
Any discrepancies were discussed and solved as necessary. 
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3 RESULTS 
  
3.1. Literature search results 
 
A schematic description of the search results is given as a flow diagram in Figure 1. 
In detail, the initial search yielded 104 articles, 26 of which were excluded as they were 
duplicates and another 67 after carefully reading titles and abstracts.  
11 studies qualified for detailed full text review.  
3 of these were excluded because they  
(1) investigated needeling effects in non-acupunture points on the buttock (Carlsson et al., 
2006),  
(2) examined nocebo-induced itch in atopic dermatitis patients by functional magnet 
resonance imaging but did not apply acupuncture  (Napadow et al., 2015) and  
(3) described a temperature modulated histamine-itch model in lesional and non-lesional 
skin in atopic dermatitis patients to evaluate itch perception by functional magnet 
resonance imaging and psychophysical test but also did not apply acupuncture  (Pfab et 
al., 2010).  
The remaining 8 studies are discussed in detail in the discussion section and detailed in 
Tables 1-3.  
Shortly, three of them had to be excluded because they describe one single acupuncture 
session to treat histamine induced itch in healthy volunteers: Belgrade et al., 1984; 
Lundeberg et al., 1987; and Pfab  et al., 2005.  
Another three studies had to be excluded because they investigated one single 
acupuncture treatment to treat allergen induced itch in patients with atopic dermatitis: Pfab  
et al., 2010; Pfab et al., 2012; and Napadow et al., 2014.  
Finally, only 2 studies described the treatment of atopic itch by repeated treatments of 
acupuncture points over several sessions over some time in clinical settings.  
One of them, however, by acupressure (Lee et al., 2012), the other one by acupuncture 
(Pfab et al., 2011). The latter was however not sufficiently controlled and therefore 
excluded as well as the first one because it was on self-applied acupressure (and not on 
acupuncture).  
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In summary we did not find any studies that were eligible to be included in this systematic 
review.  
 
 
 
Figure 1 - Flow chart Literature search 
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4. DISCUSSION 
 
 
4.1. Summary of main evidence 
 
As stated in the Results section no studies were eligible to be included in this systematic 
review. The main reasons are described in the Results section above and visualized in 
brief in Figure 1. 
 
It seems nevertheless reasonable to discuss eight of the eleven full-text-evaluated studies 
in more detail since they may give input as to where further research seems to be most 
valuable. These 8 papers are therefore detailed in Tables 1-3 with regard to (1) author 
and publication year; (2) study design; (3) number of individuals in treatment and control 
groups; (4) participants’ age; (5) and gender; (6) diagnostic criteria for AD (where 
applicable); (7) allergen used (where applicable); (8) Treatment(s): Acupoint(s) / Duration / 
Frequency / Comedications (where applicable); (9) Control Intervention(s); (10) Outcome 
measure(s); and (11) results. Side effects were not reported in any of the studies and are 
therefore not listed seperately.    
 
 
4.1.1 Treatment of histamine induced itch 
 
The oldest study identified dates back to 1984: Belgarde and coworkers asked whether 
acupuncture would be able to modify the onset, duration and flare size of histamine-
induced itch in 25 healthy volunteers. All participants were treated with acupuncture, 
pseudoacupuncture or no intervention 15 min prior to an intradermal injection of histamine 
on the left forearm. They used needle acupuncture at LI 11 (on the left elbow) and 
electroacupuncture on the right lower leg (SP6; 5–7 cm proximal to the medial malleolus 
and SP10; 1–2 cm above the medial upper border of the patella). Placebo-acupuncture 
treatment consisted of needeling closely to but not on classical acupuncture points. 
Acupuncture reduced duration and intensity of itch at a time point and histamine induced 
flare size. The timing of onset of itch and maximal itch intensity were not significantly 
modified. Needling at acupuncture points resulted in smaller flares and lower intensity of 
itch than placebo-acupuncture. 
 A second study on histamine-induced itch in healthy volunteers was published three 
years later by Lundeberg et al. (1987): they asked if histamine-induced itch could be 
prevented by  or reduced using pseudo-acupuncture (needles inserted superficially at real 
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acupuncture points), needle acupuncture and/or electroacupuncture (2 and 80 Hz) in 10 
volunteers. Acupuncture points utilized were (LU3 and LU4 situated on the upper radial 
part of m. biceps brachii) - very close to the area where histamine was injected 
intradermally; proximal to the pruritic area (LU1 and LU2 situated in front of the shoulder 
joint) in the same conduit and extrasegmentally on the lower leg (H6 and H5, both situated 
on the medial aspect of the lower leg about 15–22 cm above the medial malleolus) in 
another conduit (meridian). Pseudo-acupuncture consisted of very superficially needeling 
the same points. Acupuncture and electro-acupuncture but not pseudo-acupuncture at the 
site of the histamine injection or close to it reduced the maximal intensity. The duration of 
itch was not changed significantly. 
The third study on histamine-induced itch in healthy volunteers was published by Pfab and 
coworkers in 2005: they treated LI 11 and compard with placebo-acupuncture at a non-
acupoint in the same dermatome (C6) and no intervention 15 minutes before a histamine 
prick induced itch. Acupuncture at LI11 reduced itch intensity compared to pseudo-
acupuncture and no acupuncture and lead to a reduced flare size compared to no 
acupuncture but not compared to pseudoacupuncture. 
A detailed data extraction of these three studies is given in Table 1 below. 
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4.1.2 Treatment of allergen induced itch 
 
Three other studies found in this search examined allergen prick induced itch in atopic 
patients with known type-I allergy to the respective allergens.  
 
Two studies by the same group around Pfab and coworkers were published 2010 and 
2012, respectively. They found that  acupuncture significantly reduced allergen-induced 
itch intensity when compared with placebo and no treatment tested in 30 individuals (Pfab 
et al., 2010), and that electroacupuncture was more effective than the orally applied 
antihistamine cetirizine (Pfab et al., 2012), when used abortively rather than 
preventatively. In the latter patient- and examiner-blinded, randomized, placebo-controlled 
crossover trial comparing electroacupuncture to the oral antihistamine cetirizine in 20 
adults with AD, abortive verum acupuncture significantly reduced allergen induced itch, 
when compared to both placebo and no intervention controls (Pfab et al., 2012). Despite 
the lack of clearly listed diagnostic criteria for AD in these two studies, both stated that 
participating subjects had to have a type I hypersensitivity to (at least) an aeroallergen, 
which is commonly seen in AD. The studies also mentioned that participants had to have 
a score of > 18 or >20, respectively on the SCORAD, a validated outcome measure 
instrument for AD. One of these studies also mentioned having recruited subjects from an 
outpatient clinic and had "AD diagnosed". Both studies were crossover studies (one with 
three arms and the other one with seven). The studies involved itch provocation by 
exposure to a known allergen and the evaluation of a single acupuncture session on the 
itch evoked as measured by preventive (when acupuncture was conducted before itch 
provocation) and direct (or "abortive" - when acupuncture was applied after itch 
provocation) effects. The outcome measures evaluated were itch intensity measured by 
VAS, the Eppendorf Itch Questionnaire (EIQ), and sizes of weal and flare.  
 
Both studies therefore aimed at amelioration of allergen-induced and histamine-mediated 
itch in AD by acupuncture, rather than the management of AD as a disease. Both studies 
concluded that acupuncture significantly reduced type I hypersensitivity itch reactions, and 
may therefore be useful in the management of itch, urticaria or eczema in atopic patients.  
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Thirdly, Napadow and coworkers published 2014 a very sophisticated functional magnetic 
resonance imaging (fMRI) study investigating the underlying brain circuitry supporting 
allergen-induced itch reduction in AD patients receiving acupuncture, oral antihistamine, 
or placebo treatments. This study included 14 individuals and showed the greatest itch 
reduction following acupuncture therapy. In addition, acupuncture was associated with a 
greater reduction in putamen activity, which is an area implicated in the urge to scratch. 
Following these authors, acupuncture appears to be an effective adjunct antipruritic 
treatment strategy in the setting of atopic itch. 
A detailed data extraction of these three studies is given in Table 2 below. 
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4.1.3 Treatment of atopic itch in a clinical setting 
 
Finally two studies targeting atopic itch by repeated treatments of acupuncture points over 
several sessions over some time in clinical settings were identified. One of them, 
however, by acupressure (Lee et al., 2012), the other one by acupuncture (Pfab et al., 
2011). The latter was however not sufficiently controlled and therefore excluded as well as 
the first one because it was on self-applied acupressure.  
 
Pfab et al. published in 2011 a single-blind pilot study of 5 patients and 5 control subjects 
with a  history of AD for > 10 years, a disease severity by SCORAD > 20, and allergic 
rhinitis with sensitization to timothy grass and European house dust mite. The study 
compared twice-weekly acupuncture treatments for 10 sessions (33 days) with no 
intervention, and evaluated disease severity using SCORAD, and itch intensity using VAS 
and basophil (CD68) activation as an experimental side study. The authors found 
significant reductions in VAS, itch intensity and basophil activation. However the SCORAD 
of both arms did not differ significantly after the treatment period. However, class I-II 
topical corticosteroid therapy was allowed and not controlled for (which was one main 
reason for exclusion from the systematic part of the review - not giving the individual 
acupuncture points for each patient being the other one).The authors concluded that 
acupuncture maybe able to modify  IgE-mediated allergic disease (Pfab et al., 2011). 
 
 
Lee et al. chose self applied acupressure as treatment for 15 patients with moderate-to-
severe AD  in  an investigator-blinded trial. Their study showed that self applied 
acupressure with a 1.2 mm small titanium bead to massage acupoint LI11 on the arm for 
3 minutes 3 times per week for 1 month significantly improved pruritus (p < 0.04), 
lichenification (p < 0.03) and Investigator Global Assessment (IGA) (p < 0.03) scores. The 
overall Eczema Area and Severity Index (EASI) scores of the patients remained however 
unchanged. The control patients had no intervention in addition to their basic emollients 
and OTC (over the counter treatment) remedies that were also allowed but not rigorously 
controlled for in the treatment or the groups.  
 
A detailed data extraction of these three studies is given in Table 3 below.   
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4.2. Acupunture points mostly used in the studies discussed in detail  
 
 
 
Four of the eleven named acupuncture points used as treatment in the eight studies 
discussed in detail above: LU1, LU2, LU3, LU4; HT3; LI 4, LI11; SP10, SP6; ST34, ST36 
will be explained in some detail because at least some of them have been dubbed 
"classical acupuncture points" for cutaneous pruritus (Pfab et al., 2005; Augustin, 2012b).  
 
As far as LU1, LU2, LU3, LU4 are concerned were these most likely chosen because they 
were either very close to the area of induction of itch ("local points") for LU3 and LU 4 or 
on the same conduit (for LU1 and LU2) in the experiments on histamine induced itch by 
Lundeberg and coworkers, 1987.  
 
 
The by far most frequently used acupuncture point in all studies was: 
 
LI11 / large intestine 11/ IC 11/ Quchi / stagnum curvum / cools xue on the extima 
 
 
 
 
 
 
Figure 2 - Acupuncture point LI11 
 
Position: within the crease situated radially above the elbow joint. 
Effects of stimulation: Expelling ventus, opening up the extima, checking calor, draining 
humor, harmonizing constructive energy and the xue. 
Symptoms and Indications: …dryness of the skin; exanthema and ulcerations, itching all 
over the body…. (Porkert & Hempen 1995b; Xinnong 1987; Greten, 2017a). 
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Situated on the same conduit and therefore logically also applicable is: 
 
LI4 / large intestine 4/ IC 4 / Hegu / valles coniunctae / dispels ventus and distributes 
defensive qi (also a so- called c,v, h-point)  
 
 
 
 
 
 
 
 
Figure 3 - Acupuncture point LI4 
 
Position: At the radial side, approximately in the center oft he 2nd metacarpal, in a 
concavity. 
Effects of stimulation: Dispelling ventus-heteropathies, releasing the extima, pressing 
down pain, unclogging reticular conduits. 
Symptoms and Indications: External ventus…., Internal ventus….exanthemas… (Porkert 
& Hempen 1995b; Xinnong 1987; Greten, 2017a). 
 
Nota bene: Greten (2017a) mentions that LI4 in some sources is named the "aspirine-
point" referring to a particular potency against pain - as stated above in the text itch and 
pain share some modes of reception and transmission and therefore this dual effect 
seems logical. 
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SP10 / spleen 10 / L10 / Xuehai / mare xue 
 
 
Figure 4 - Acupuncture point SP10 
 
Position: 2 PI vertically over the upper, medial margin oft he patella. 
Effects of stimulation: Regulating the xue, correcting disorders of menstruation. 
Symptoms and Indications: …itch on different parts oft he body. (Porkert & Hempen 
1995b; Xinnong 1987; Greten, 2017a). 
 
Nota bene: Greten (2017b) mentions an extrapoint called nidulus bestiolorum and 
located 1 PC above SP10 that particularly treats itch. This point is also mentioned by 
Xennong (1987) in the same context and named Baichongwo ("hundred insect burrow"), 
and in other sources called EX-LE3. 
 
  
 37 
 
 
 
ST36 / stomach 36 / S 36 / Zusanli / vicus tertius pedis/ “the Soldier’s Point” 
 
 
 
  
 
 
 
 
 
Figure 5 - Acupuncture point ST36 
 
Position: 3 PI below the foramen S35, hence at the lower margin of the patella, and at one 
finger´s width (1 PC) from the anterior margin of the tibia near the tuberositas tibiae. 
Effects of stimulation: Stabilizing and regulating the lienal and the stomach orb, 
harmonizing the qi and the xue. 
Symptoms and Indications: …acute and chronic disorders affecting those people whose 
assimilative and integrative capacities are overtaxed by civilization: 
….asthma….allergies…. (Porkert & Hempen 1995b; Xinnong 1987; Greten, 2017a). 
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4.3. Acupunture point selection and combination  
 
Importantly, Pfab and Coworkers (2011) used in the only study that investigated the effect 
of acupuncture on atopic dermatitis and itch individual acupuncture points - selected by 
an "experienced acupuncturist" - but not given in detail in the publication - together with a 
"standard set" of points which were: LI11, LI4, ST36 and SP10 (Pfab et al. 2011). 
 
Similarly the Heidelberg School recommends to always individualize acupuncture 
treatments according to the TCM diagnosis based on several different diagnostic criteria 
(Greten, 2016 and 2017a/b). Nevertheless certain clinical signs and symptoms used to 
describe AD or itch in Western medicine can be related to TCM heteropathies according 
to the Heidelberg model as well and are exemplified below in Table 4:   
 
Symptom Causes (TCM) Acupuncture points 
Dry, scaling, pale skin lack of fluids 
lack of xue (yin) 
LU 5, KI 7, SP 6, SP 10 (P 5, R 7, L 6, L 10)  
 
Red skin calor, hepaticity ST 44, LI 11 (S 44, IC 11)  
 
Itching ventus, hepaticity H 3, LI 11, LU 5 (H 3, IC 11, P 5) 
 (bleeding), nidus bestiolorum  (EX-LE 3) 
 
Table 4 - Symptoms, causes and acupuncture points in dermatology (translated and 
modified after: Greten, 2017b) 
 
Particularly LI11 and SP10 occur in most of the studies, textbooks and models. 
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4.4. Contols: no intervention vs. pseudoacupuncture vs. placebo-acupuncture 
 
In the studies described various methods and modes of interventions for the control 
groups were utilized: no intervention, placebo-acupuncture (needles penetrating and at 
non-acupoint(s), pseudo-acupuncture (needles not penetrating but at acupoint(s), 
placebo-pseudo-acupuncture (at non acupoint(s) and non penetrating), in some studies 
also as electroacupuncture. Evidence exists however, that placebo procedures as 
described can as well have treatment effects superior to no intervention or even active 
treatments (Lundeberg et al. 2011). On the other hand very sophisticated but also 
complex double-blind-placebo-controlled study schemes have been performed and 
published (Karner et al., 2013) or planned (Seca et al., 2016).  
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4.5. Limitations 
 
The main limitation for the primary goal of this review, namely to identify high quality 
studies to evaluate the clinical value of acupuncture alone in the treatment of itch in 
patients with atopic eczema is the paucicity of studies on the topic in general, RCTs in 
particular and the absence of any study meeting all inclusion criteria. 
One could argue that this systematic literature review searched only three and Western 
databases and only articles with at least an English abstract and therefore may have 
overlooked important studies. This seems, however, rather unlikely since other systematic 
reviewers that included many more databases did not find anymore relevant studies in the 
relatively recent past. In addition it is very likely that Eastern medicine researchers would 
have published their results from high quality RCTs on the topic such that they would have 
been found by this or the above mentioned systemic reviews.  
Limitations concerning the extended discussion of interesting studies that failed inclusion 
but nevertheless seemed worthwhile to be explored into depth are the low number of 
studies (2), the low patient numbers enrolled (15 and 10, respectively (Lee et al, 2012; 
Pfab et al. 2010)), and the lack of adequate control for concomitant basic therapies (such 
as moisturizers), that alone can have dramatic effects on itch. Finally the acupuncture 
points were individualized in the latter study and are therefore not comparable. 
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4.6. Suggestions for further research 
 
RCTs on the clinical value of acupuncture alone - as monotherapy - as only therapeutic 
intervention at a given time - in the treatment of itch in patients with atopic eczema would 
be needed. These would have to be rigorously controlled for several concomitant factors 
such as basic therapy with moisturizers, active concomitant  therapy with e.g. local 
corticosteroids, allergen exposure (e.g. seasonal allergies) and many others. Furthermore 
a double-blind placebo controlled setting for the acupuncture vs. placebo-acupuncture 
would indeed be possible, as exemplified in acupuncture studies in the past (Karner et al., 
2013) but very laborious and therefore probably hard to establish.  
 
The often complex personalities of AD patients that seemingly also influence itch 
reception and perception on various levels may prevent control of studies as well.  
 
Therefore it may be virtually impossible to design or even more difficult to carry out these 
studies - which in turn may explain, why such studies have not been done to date. 
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5. CONCLUSION 
 
In conclusion, this systematic literature review did not find high quality data to judge the 
effect of acupuncture as single treatment (monotherapy) for atopic itch in a clinical setting 
and therefore no evidence-based recommendations can be made based on this review.  
 
This is in contrast with several other systemic reviews that have been published in recent 
years, some of which claimed to have found such studies and therefore included them into 
their reviews (Ma et al. 2015; Yu et al. 2015) and very recently (Shi et al. 2017).  
 
Others reviewers were more cautious and therefore in line with the conclusion here in that 
they stated that the data available are too sparse and too inhomogeneous (Viera et al. 
2016)  or came to the same result as the review presented here and excluded the studies 
completely (Tan et al. 2015). 
   
Several studies demonstrated however effectiveness of acupuncture in ameliorating 
histamine induced itch in healthy volunteers and atopic individuals as well.  
There are also several studies on the effectiveness of allergen induced itch in atopic 
subjects. 
Finally two studies showed ameliorating effects of acupuncture and acupressure on atopic 
itch in clinical practice, however not in a RCT and only with very small patient numbers.  
 
Therefore rigorously designed and controlled RCTs to assess the efficacy of acupuncture 
in the management of atopic itch in clinical practice would be needed to clarify its 
usefullness as monotherapy. It may however for several reasons not be realistic that such 
studies will ever be performed. First, because patients, particularly those suffering from 
severe itch may not accept acupuncture as monotherapy. Secondly and related to the 
latter it would be very difficult to control for concomitant basic therapies such as 
moisturizers etc. over longer periods of time.  
 
Notably no side effects were reported through all studies and also in all reviews cited in 
this work, although many of these papers stated that they explicitely investigated / 
searched for them. This may indicate that acupuncture is a safe intervention in AD 
patients. 
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Therefore the conclusion of this review is that acupuncture seems to be one possible 
treatment option to ameliorate atopic itch and thereby also be beneficial in supporting the 
treatment of atopic eczema but not necessarily as monotherapy.     
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